The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanguay, D. A.
Right arrow Articles by Chiles, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanguay, D. A.
Right arrow Articles by Chiles, T. C.

The Journal of Immunology, Vol 156, Issue 2 539-548, Copyright © 1996 by American Association of Immunologists


ARTICLES

Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D- type cyclin in mature B lymphocytes

DA Tanguay and TC Chiles
Department of Biology, Boston College, Chestnut Hill, MA 02167, USA.

We examined the expression of the cyclin-dependent kinase 4, p34PSK- J3/cdk4 protein, in small dense, activated, and proliferating primary B lymphocytes. A small steady state level of cdk4 synthesis was detected in resting B cells. Stimulation of resting B cells with mitogenic amounts of F(ab')2 fragments of goat anti-mouse IgM (anti-Ig) resulted in increased synthesis of cdk4 protein during the mid to late G1 phase of the cell cycle; LPS or the combination of phorbol ester and calcium ionophore also elevated cdk4 levels. Resting B cells that we rendered competent by treatment with IL 4 or low doses of anti-Ig or, alternatively, were activated by phorbol ester or ionomycin alone also exhibited heightened cdk4 protein levels. Subsequent analysis of potential cdk4 regulatory subunit D-type cyclins revealed that cyclin D2, not cyclin D1 or D3, is expressed in primary mature B lymphocytes. The induction of cyclin D2 synthesis in response to mitogenic anti-Ig paralleled cdk4 expression; however, IL-4 or low dose anti-Ig alone did not increase the rate of de novo cyclin D2 synthesis above that of resting B cells. The significance of the lack of cyclin D2 regulation by competence-inducing growth factors was demonstrated, in that only mitogenic factors that stimulated DNA synthesis 1) led to the formation of stable cyclin D2/cdk4 holoenzyme complexes during G1 phase progression, and 2) afforded the isolation of anti-cyclin D2 or anti- cdk4 immunoprecipitates that phosphorylated retinoblastoma. These findings suggest a role for these proteins during the mid to late G1 phase progression and possibly the G1/S phase transition in primary mature B lymphocytes.


This article has been cited by other articles:


Home page
J. Immunol.Home page
N. Marzo, S. Ortega, T. Stratmann, A. Garcia, M. Rios, A. Gimenez, R. Gomis, and C. Mora
Cyclin-Dependent Kinase 4 Hyperactivity Promotes Autoreactivity in the Immune System but Protects Pancreatic Cell Mass from Autoimmune Destruction in the Nonobese Diabetic Mouse Model
J. Immunol., January 15, 2008; 180(2): 1189 - 1198.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Mataraza, J. R. Tumang, M. R. Gumina, S. M. Gurdak, T. L. Rothstein, and T. C. Chiles
Disruption of Cyclin D3 Blocks Proliferation of Normal B-1a Cells, but Loss of Cyclin D3 Is Compensated by Cyclin D2 in Cyclin D3-Deficient Mice
J. Immunol., July 15, 2006; 177(2): 787 - 795.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ely, M. Di Liberto, R. Niesvizky, L. B. Baughn, H. J. Cho, E. N. Hatada, D. M. Knowles, J. Lane, and S. Chen-Kiang
Mutually Exclusive Cyclin-Dependent Kinase 4/Cyclin D1 and Cyclin-Dependent Kinase 6/Cyclin D2 Pairing Inactivates Retinoblastoma Protein and Promotes Cell Cycle Dysregulation in Multiple Myeloma
Cancer Res., December 15, 2005; 65(24): 11345 - 11353.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Goulvestre, C. Chereau, C. Nicco, L. Mouthon, B. Weill, and F. Batteux
A Mimic of p21WAF1/CIP1 Ameliorates Murine Lupus
J. Immunol., November 15, 2005; 175(10): 6959 - 6967.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. K. A. Mongini, J. K. Inman, H. Han, S. L. Kalled, R. J. Fattah, and S. McCormick
Innate Immunity and Human B Cell Clonal Expansion: Effects on the Recirculating B2 Subpopulation
J. Immunol., November 1, 2005; 175(9): 6143 - 6154.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Huang, M. Di Liberto, A. F. Cunningham, L. Kang, S. Cheng, S. Ely, H.-c. Liou, I. C. M. MacLennan, and S. Chen-Kiang
Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1
PNAS, December 21, 2004; 101(51): 17789 - 17794.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. C. Chiles
Regulation and Function of Cyclin D2 in B Lymphocyte Subsets
J. Immunol., September 1, 2004; 173(5): 2901 - 2907.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Piatelli, C. Wardle, J. Blois, C. Doughty, B. R. Schram, T. L. Rothstein, and T. C. Chiles
Phosphatidylinositol 3-Kinase-Dependent Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 and NF-{kappa}B Signaling Pathways Are Required for B Cell Antigen Receptor-Mediated Cyclin D2 Induction in Mature B Cells
J. Immunol., March 1, 2004; 172(5): 2753 - 2762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Piatelli, C. Doughty, and T. C. Chiles
Requirement for a hsp90 Chaperone-dependent MEK1/2-ERK Pathway for B Cell Antigen Receptor-induced Cyclin D2 Expression in Mature B Lymphocytes
J. Biol. Chem., March 29, 2002; 277(14): 12144 - 12150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Tanguay, T. P. Colarusso, C. Doughty, S. Pavlovic-Ewers, T. L. Rothstein, and T. C. Chiles
Cutting Edge: Differential Signaling Requirements for Activation of Assembled Cyclin D3-cdk4 Complexes in B-1 and B-2 Lymphocyte Subsets
J. Immunol., April 1, 2001; 166(7): 4273 - 4277.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Richards, S. H. Dave, C.-H. G. Chou, A. A. Mamchak, and A. L. DeFranco
Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen
J. Immunol., March 15, 2001; 166(6): 3855 - 3864.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. F. Modiano, J. Mayor, C. Ball, M. K. Fuentes, and D. S. Linthicum
CDK4 Expression and Activity Are Required for Cytokine Responsiveness in T Cells
J. Immunol., December 15, 2000; 165(12): 6693 - 6702.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. T. Hoge, S. B. Hendrickson, and W. H. Burns
Murine Gammaherpesvirus 68 Cyclin D Homologue Is Required for Efficient Reactivation from Latency
J. Virol., August 1, 2000; 74(15): 7016 - 7023.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
N. Solvason, W. W. Wu, D. Parry, D. Mahony, E. W.-F. Lam, J. Glassford, G. G. B. Klaus, P. Sicinski, R. Weinberg, Y. J. Liu, et al.
Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development
Int. Immunol., May 1, 2000; 12(5): 631 - 638.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Swart, D. M. Bergeron, and T. C. Chiles
Identification of a Membrane Ig-Induced p38 Mitogen-Activated Protein Kinase Module That Regulates cAMP Response Element Binding Protein Phosphorylation and Transcriptional Activation in CH31 B Cell Lymphomas
J. Immunol., March 1, 2000; 164(5): 2311 - 2319.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Tanguay, S. Pavlovic, M. J. Piatelli, J. Bartek, and T. C. Chiles
B Cell Antigen Receptor-Mediated Activation of Cyclin-Dependent Retinoblastoma Protein Kinases and Inhibition by Co-Cross-Linking with Fc{gamma} Receptors
J. Immunol., September 15, 1999; 163(6): 3160 - 3168.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. A. Tanguay, T. P. Colarusso, S. Pavlovic, M. Irigoyen, R. G. Howard, J. Bartek, T. C. Chiles, and T. L. Rothstein
Early Induction of Cyclin D2 Expression in Phorbol Ester-responsive B-1 Lymphocytes
J. Exp. Med., June 7, 1999; 189(11): 1685 - 1690.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Nonaka, K. Azumi, X. Ji, C. Namikawa-Yamada, M. Sasaki, H. Saiga, A. W. Dodds, H. Sekine, M. K. Homma, M. Matsushita, et al.
Opsonic Complement Component C3 in the Solitary Ascidian, Halocynthia roretzi
J. Immunol., January 1, 1999; 162(1): 387 - 391.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. F. Wagner, M. Hleb, N. Hanna, and S. Sharma
A Pivotal Role of Cyclin D3 and Cyclin-Dependent Kinase Inhibitor p27 in the Regulation of IL-2-, IL-4-, or IL-10-Mediated Human B Cell Proliferation
J. Immunol., August 1, 1998; 161(3): 1123 - 1131.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. M. Ott, J. Bartkova, J. Bartek, A. Durr, L. Fischer, G. Ott, H. K. Muller-Hermelink, and H. Kreipe
Cyclin D1 Expression in Mantle Cell Lymphoma Is Accompanied by Downregulation of Cyclin D3 and Is Not Related to the Proliferative Activity
Blood, October 15, 1997; 90(8): 3154 - 3159.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. C. Horne, K. L. Donaldson, G. L. Goolsby, D. Tran, M. Mulheisen, J. W. Hell, and A. F. Wahl
Cyclin G2 Is Up-regulated during Growth Inhibition and B Cell Antigen Receptor-mediated Cell Cycle Arrest
J. Biol. Chem., May 9, 1997; 272(19): 12650 - 12661.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E.-L. Tan, S.-C. Wong, S. K.-E. Gan, S. Xu, and K.-P. Lam
The Adaptor Protein BLNK Is Required for B Cell Antigen Receptor-induced Activation of Nuclear Factor-kappa B and Cell Cycle Entry and Survival of B Lymphocytes
J. Biol. Chem., June 1, 2001; 276(23): 20055 - 20063.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.